Published in Dtsch Arztebl Int on April 22, 2011
An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors. Sci Transl Med (2015) 1.44
Radiotherapy and Hormone Treatment in Prostate Cancer. Dtsch Arztebl Int (2016) 1.21
Radiation-induced carotid artery stenosis: a comprehensive review of the literature. Interv Neurol (2014) 0.77
MR-guidance--a clinical study to evaluate a shuttle- based MR-linac connection to provide MR-guided radiotherapy. Radiat Oncol (2014) 0.77
Positioning accuracy during VMAT of gynecologic malignancies and the resulting dosimetric impact by a 6-degree-of-freedom couch in combination with daily kilovoltage cone beam computed tomography. Radiat Oncol (2015) 0.75
Internet-based computer technology on radiotherapy. Rep Pract Oncol Radiother (2017) 0.75
Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys (1994) 4.50
Overview of image-guided radiation therapy. Med Dosim (2006) 3.07
Tomotherapy. Semin Radiat Oncol (1999) 2.16
Image-guided radiotherapy: rationale, benefits, and limitations. Lancet Oncol (2006) 1.86
Megavoltage cone-beam CT: system description and clinical applications. Med Dosim (2006) 1.74
Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. Int J Radiat Oncol Biol Phys (2008) 1.63
4D-CT-based target volume definition in stereotactic radiotherapy of lung tumours: comparison with a conventional technique using individual margins. Radiother Oncol (2009) 1.39
The use of megavoltage CT (MVCT) images for dose recomputations. Phys Med Biol (2005) 1.36
Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol (2008) 1.22
Radiation dose from kilovoltage cone beam computed tomography in an image-guided radiotherapy procedure. Int J Radiat Oncol Biol Phys (2009) 1.20
Evaluation of image-guidance strategies in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys (2007) 1.09
Review of image-guided radiation therapy. Expert Rev Anticancer Ther (2007) 1.09
Evaluation of image-guidance protocols in the treatment of head and neck cancers. Int J Radiat Oncol Biol Phys (2006) 1.09
Dose-guided radiation therapy with megavoltage cone-beam CT. Br J Radiol (2006) 1.02
Dynamic targeting image-guided radiotherapy. Med Dosim (2006) 1.02
Megavoltage CT in helical tomotherapy - clinical advantages and limitations of special physical characteristics. Technol Cancer Res Treat (2009) 0.95
Dose calculation using megavoltage cone-beam CT. Int J Radiat Oncol Biol Phys (2007) 0.93
Accuracy of ultrasound-based (BAT) prostate-repositioning: a three-dimensional on-line fiducial-based assessment with cone-beam computed tomography. Int J Radiat Oncol Biol Phys (2008) 0.90
Kilovoltage CT using a linac-CT scanner combination. Br J Radiol (2006) 0.90
Megavoltage imaging, megavoltage cone beam CT and dose-guided radiation therapy. Front Radiat Ther Oncol (2007) 0.89
Image-guided radiation therapy (IGRT) in gastrointestinal tumors. JOP (2006) 0.89
Adverse effect of a distended rectum in intensity-modulated radiotherapy (IMRT) treatment planning of prostate cancer. Radiother Oncol (2006) 0.87
Target motion variability and on-line positioning accuracy during external-beam radiation therapy of prostate cancer with an endorectal balloon device. Strahlenther Onkol (2006) 0.86
IGRT with helical tomotherapy--effort and benefit in clinical routine. Strahlenther Onkol (2007) 0.85
Image-guided radiation therapy: current and future directions. Future Oncol (2006) 0.83
Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy. Strahlenther Onkol (2009) 0.83
Quantitative assessment of image-guided radiotherapy for paraspinal tumors. Int J Radiat Oncol Biol Phys (2009) 0.82
[Stereotactic irradiation of lung tumors]. Radiologe (2004) 0.80
Catch me if you can--the use of image guidance in the radiotherapy of an unusual case of esophageal cancer. Strahlenther Onkol (2009) 0.79
Colorectal cancer. Lancet (2005) 4.90
Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol (2009) 4.38
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging (2013) 3.61
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging (2014) 3.40
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med (2010) 2.97
Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine. Int J Radiat Oncol Biol Phys (2006) 2.48
Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab (2006) 2.15
Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys (2004) 2.02
Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes? Radiother Oncol (2009) 2.00
Inversion recovery TrueFISP: quantification of T(1), T(2), and spin density. Magn Reson Med (2004) 1.98
Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma. J Clin Oncol (2012) 1.90
Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg (2007) 1.85
Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci U S A (2007) 1.85
Radiation induced DNA damage and damage repair in human tumor and fibroblast cell lines assessed by histone H2AX phosphorylation. Int J Radiat Oncol Biol Phys (2006) 1.71
Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy. Cancer Res (2005) 1.62
Improvement of surgical results for pancreatic cancer. Lancet Oncol (2013) 1.60
Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol (2005) 1.60
Comparison of 60cobalt and 192iridium sources in high dose rate afterloading brachytherapy. Strahlenther Onkol (2008) 1.59
Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol (2006) 1.58
Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2002) 1.56
Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys (2007) 1.56
Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens. Int J Radiat Oncol Biol Phys (2008) 1.55
Cell type-specific association of hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein accumulation and radiobiologic tumor hypoxia. Int J Radiat Oncol Biol Phys (2004) 1.54
Intracellular visualization of prostate cancer using magnetic resonance imaging. Cancer Res (2003) 1.52
Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells. Radiother Oncol (2005) 1.51
Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys (2004) 1.51
Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys (2004) 1.50
Multidisciplinary pain management based on a computerized clinical decision support system in cancer pain patients. Pain (2009) 1.48
Investigation of the usability of conebeam CT data sets for dose calculation. Radiat Oncol (2008) 1.47
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. J Clin Oncol (2010) 1.46
A new concept for interactive radiotherapy planning with multicriteria optimization: first clinical evaluation. Radiother Oncol (2007) 1.45
Differential response of human glioblastoma cell lines to combined camptothecin and ionizing radiation treatment. Cancer Biol Ther (2007) 1.45
kV cone-beam CT-based IGRT: a clinical review. Strahlenther Onkol (2011) 1.44
Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy. Eur J Nucl Med Mol Imaging (2014) 1.43
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol (2007) 1.43
Effectiveness of radiochemotherapy on lymph node metastases in patients with stage IV oropharyngeal cancer. Oral Oncol (2004) 1.42
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC Cancer (2005) 1.42
Analysis of intrathoracic tumor mobility during whole breathing cycle by dynamic MRI. Int J Radiat Oncol Biol Phys (2004) 1.41
How to successfully implement E-learning for both students and teachers. Acad Radiol (2006) 1.41
[The effectiveness of radiation treatment in comparison with extracorporeal shockwave therapy (ESWT) in supraspinatus tendon syndrome]. Strahlenther Onkol (2002) 1.40
External beam radiotherapy in the treatment of male breast carcinoma: patterns of failure in a single institute experience. Tumori (2005) 1.40
4D-CT-based target volume definition in stereotactic radiotherapy of lung tumours: comparison with a conventional technique using individual margins. Radiother Oncol (2009) 1.39
Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer (2010) 1.38
Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res (2008) 1.36
Magnitude and clinical relevance of translational and rotational patient setup errors: a cone-beam CT study. Int J Radiat Oncol Biol Phys (2006) 1.35
Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol (2009) 1.33
Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev (2007) 1.33
Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys (2006) 1.33
Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. Radiother Oncol (2010) 1.30
Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography. Int J Radiat Oncol Biol Phys (2008) 1.29
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiat Oncol (2012) 1.28
Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys (2003) 1.27
Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys (2010) 1.27
Positioning accuracy of cone-beam computed tomography in combination with a HexaPOD robot treatment table. Int J Radiat Oncol Biol Phys (2007) 1.26
Precision of image-guided radiotherapy (IGRT) in six degrees of freedom and limitations in clinical practice. Strahlenther Onkol (2007) 1.25
Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas. J Nucl Med (2005) 1.25
Outcome and late complications of radiotherapy in patients with unicentric Castleman disease. Acta Oncol (2006) 1.24
Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma. Onkologie (2006) 1.24
Four-dimensional treatment planning for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.23
Nonrigid patient setup errors in the head-and-neck region. Strahlenther Onkol (2007) 1.23
Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol (2008) 1.22
Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol (2012) 1.21
Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. Int J Radiat Oncol Biol Phys (2008) 1.20
Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys (2005) 1.20
Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response. Radiat Oncol (2013) 1.19
Radiotherapy in adrenocortical carcinoma. Cancer (2009) 1.18
Particle therapy at the Heidelberg Ion Therapy Center (HIT) - Integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany. Radiother Oncol (2010) 1.18
Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys (2007) 1.18
A biological transporter for the delivery of peptide nucleic acids (PNAs) to the nuclear compartment of living cells. J Mol Biol (2002) 1.18
Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Radiother Oncol (2007) 1.17
Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy. Lung Cancer (2004) 1.17
Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors. Acta Oncol (2006) 1.17
Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives. Strahlenther Onkol (2007) 1.15
Radiotherapeutic alternatives for previously irradiated recurrent gliomas. BMC Cancer (2007) 1.15
Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer. BMC Cancer (2009) 1.14
Is a single respiratory correlated 4D-CT study sufficient for evaluation of breathing motion? Int J Radiat Oncol Biol Phys (2007) 1.13
Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2006) 1.13
Tumor tracking and motion compensation with an adaptive tumor tracking system (ATTS): system description and prototype testing. Med Phys (2008) 1.11
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. Oncol Rep (2008) 1.11
Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys (2006) 1.11
Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results. Invest Radiol (2004) 1.10
Ion beam radiobiology and cancer: time to update ourselves. Biochim Biophys Acta (2009) 1.09
Intensity modulated radiotherapy in the management of sacral chordoma in primary versus recurrent disease. Radiother Oncol (2010) 1.09
Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer (2010) 1.09
Stereotactic body radiation therapy in the re-irradiation situation--a review. Radiat Oncol (2013) 1.08
Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma. Int J Radiat Oncol Biol Phys (2006) 1.08
Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data. Radiat Oncol (2012) 1.08
Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells. BMC Cancer (2007) 1.07
Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery. Strahlenther Onkol (2004) 1.07
Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition. Int J Radiat Oncol Biol Phys (2010) 1.07
Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. Int J Radiat Oncol Biol Phys (2005) 1.07
A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol (2003) 1.07
Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution. Int J Radiat Oncol Biol Phys (2005) 1.06
Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients. Acta Oncol (2010) 1.06
Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique. Int J Radiat Oncol Biol Phys (2011) 1.06
Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer : beware of one-stop shops? Strahlenther Onkol (2010) 1.06
The stability of osseous metastases of the spine in lung cancer--a retrospective analysis of 338 cases. Radiat Oncol (2013) 1.05
Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: clinical implementation of the step and shoot approach and first clinical results. Radiother Oncol (2003) 1.05
Dynamic jaws and dynamic couch in helical tomotherapy. Int J Radiat Oncol Biol Phys (2009) 1.05